These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 17694389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S, Nomikos GG, Panagis G.
    Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
    [Abstract] [Full Text] [Related]

  • 3. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
    Cross-Mellor SK, Ossenkopp KP, Piomelli D, Parker LA.
    Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.
    Lisboa SF, Resstel LB, Aguiar DC, Guimarães FS.
    Eur J Pharmacol; 2008 Sep 28; 593(1-3):73-8. PubMed ID: 18691568
    [Abstract] [Full Text] [Related]

  • 8. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C, Gasperi V, Tartaglione R, Cerulli A, Terrinoni A, Bari M, De Simone C, Agrò AF, Morrone LA, Corasaniti MT, Bagetta G, Maccarrone M.
    Invest Ophthalmol Vis Sci; 2007 Jul 28; 48(7):2997-3004. PubMed ID: 17591864
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
    Seillier A, Giuffrida A.
    Neuropharmacology; 2018 Mar 01; 130():1-9. PubMed ID: 29169961
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
    Hartmann A, Fassini A, Scopinho A, Correa FM, Guimarães FS, Lisboa SF, Resstel LB.
    J Psychopharmacol; 2019 May 01; 33(5):606-614. PubMed ID: 30789299
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
    Lam FF, Luk PW, Ng ES.
    Life Sci; 2007 Mar 27; 80(16):1495-502. PubMed ID: 17275857
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A.
    Int J Neuropsychopharmacol; 2010 Apr 27; 13(3):373-86. PubMed ID: 19607756
    [Abstract] [Full Text] [Related]

  • 19. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
    Seillier A, Martinez AA, Giuffrida A.
    Neuropsychopharmacology; 2013 Aug 27; 38(9):1816-24. PubMed ID: 23563893
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.